跳到主要內容

Horn Margaret A 的 Form 4 申報

Revolution Medicines, Inc.(RVMD),2026/6/17 申報

申報編號
0001610717-26-000230
申報時間
2026/6/17
交易日
2025/6/16-2026/6/17
申報延遲
366 天遲報
10b5-1 計畫
有勾選

這份申報列了 8 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $1,497 萬。交易後 366 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Horn Margaret ACIK 0001294192高階主管(營運長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/6/15Common StockM行使選擇權取得+15,546$40.74+$633,344.04173,768直接
2026/6/15Common StockM行使選擇權取得+44,854$29.80+$1,336,649.2218,622直接
2026/6/15Common StockS賣出處分−60,400$160.17F3−$9,674,268158,222直接
2025/6/16Common StockS賣出處分−3,575$156.12F5−$558,129154,647直接
2026/6/17Common StockM行使選擇權取得+573$40.74+$23,344.02155,220直接
2026/6/17Common StockM行使選擇權取得+3,302$29.80+$98,399.6158,522直接
2026/6/17Common StockM行使選擇權取得+25,725$26.50+$681,712.5184,247直接
2026/6/17Common StockS賣出處分−29,600$160.12F7−$4,739,552154,647直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/6/15Common StockM行使選擇權處分−15,546$0.00$075,648直接
2026/6/15Common StockM行使選擇權處分−44,854$0.00$075,052直接
2026/6/17Common StockM行使選擇權處分−573$0.00$075,075直接
2026/6/17Common StockM行使選擇權處分−3,302$0.00$071,750直接
2026/6/17Common StockM行使選擇權處分−25,725$0.00$0114,275直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

This transaction was executed in multiple trades in prices ranging from $160.00 to $160.3550, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F5

This transaction was executed in multiple trades in prices ranging from $156.1105 to $156.8250, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades in prices ranging from $160.00 to $160.48, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)